Folyóiratcikkek tallózása szerző szerint "Danese, S"

1-7 / 7

Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, P; Cunha-Santos, A; Aires, da Silva F; Alcobia, A; Delgado, Alves J; Carey, J; Doerner, T; Eurico, Fonseca J; Palmela, C; Lima, Vieira C; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, Péter László; Danese, S (2018)
Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Baji, Petra; Gulácsi, László; Brodszky, Valentin; Végh, Zsuzsanna; Danese, S; Irving, PM; Peyrin, Biroulet L; Schreiber, S; Rencz, Fanni; Lakatos, Péter László; Péntek, Márta (2018)

Background: In clinical practice, treatment sequences of biologicals are applied for active fistulising Crohn's disease, however underlying health economic analyses are lacking.
Development of an index to define overall disease severity in IBD

Siegel, CA; Whitman, CB; Spiegel, BM; Feagan, B; Sands, B; Loftus, EV Jr; Panaccione, R; D'Haens, G; Bernstein, CN; Gearry, R; Ng, SC; Mantzaris, GJ; Sartor, B; Silverberg, MS; Riddell, R; Koutroubakis, IE; O'Morain, C; Lakatos, Péter László; McGovern, DP; Halfvarson, J; Reinisch, W; Rogler, G; Kruis, W; Tysk, C; Schreiber, S; Danese, S; Sandborn, W; Griffiths, A; Moum, B; Gasche, C; Pallone, F; Travis, S; Panes, J; Colombel, JF; Hanauer, S; Peyrin-Biroulet, L (2018)
Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD innitiative

Danese, S; Fiorino, G; Mary, JY; Lakatos, Péter László; D’Haens, G; Moja, L; D’Hoore, A; Panes, J; Reinisch, W; Sandborn, WJ; Travis, SP; Vermeire, S; Peyrin-Biroulet, L; Colombel, JF (2015)
Discontinuation of Infliximab in Patients With Ulcerative Colitis is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

Fiorino, G; Cortes, PN; Ellul, P; Felice, C; Karatzas, P; Silva, M; Lakatos, Péter László; Bossa, F; Ungar, B; Sebastian, S; Furfaro, F; Karmiris, K; Katsanos, KH; Muscat, M; Christodoulou, DK; Maconi, G; Kopylov, U; Magro, F; Mantzaris, GJ; Armuzzi, A; Boscà-Watts, MM; Ben-Horin, S; Bonovas, S; Danese, S (2016)
Dose optimization is effective in ulcerative colitis patients losing response to infliximab: A collaborative multicentre retrospective study.

Cesarini, M; Katsanos, K; Papamichael, K; Ellul, P; Lakatos, Péter László; Caprioli, F; Kopylov, U; Tsianos, E; Mantzaris, GJ; Ben-Horin, S; Danese, S; Fiorino, G (2014)

BACKGROUND: Subjects maintained on infliximab scheduled therapy for inflammatory bowel disease may require dose optimization due to secondary loss of response. There are limited data on infliximab dose optimization for ...
ECCO Position statement on the use of biosimilars for inflammatory bowel disease – An update

Danese, S; Fiorino, G; Raine, T; Ferrante, M; Kemp, K; Kierkus, J; Lakatos, Péter László; Mantzaris, G; van der Woude, J; Panes, J; Peyrin-Biroulet, L (2017)

1-7 / 7

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban
Ebben a gyűjteményben

Hozzáférésem

Bejelentkezés

Folyóiratcikkek tallózása szerző szerint "Danese, S"

DSpace/Manakin Repository

Folyóiratcikkek tallózása szerző szerint "Danese, S"

Keresés

Tallózás

Teljes repozitórumban

Ebben a gyűjteményben

Hozzáférésem